🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lynne D. Berry

Berry & Associates (United States)

ORCID: 0000-0001-7700-2918

Also affiliated with Vanderbilt University Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.9Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution

Cell(2020)10.1016/j.cell.2020.03.053
Top 4%
5.6DataRank
Top 4%609 citations

Aviv Regev, Philipp Oberdoerffer, Tal Nawy, Anna Hupalowska, Jennifer E. Rood +92 more

Papers

Driven by 7 papers — median percentile 69. Top paper: “The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution”.

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution

Cell(2020)10.1016/j.cell.2020.03.053
Top 4%
5.6DataRank
Top 4%609 citations

Aviv Regev, Philipp Oberdoerffer, Tal Nawy, Anna Hupalowska, Jennifer E. Rood +92 more

Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.27211
N/A
1.1DataRank · unranked
29 citations

Chih–Yuan Hsu, Lynne D. Berry, Paul A. Bunn, Yu Shyr, Emily Pei-Ying Lin

Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps

Cell(2021)10.1016/j.cell.2021.11.031
N/A
0.871DataRank · unranked
332 citations

Cherie’ R. Scurrah, Eliot T. McKinley, Alan J. Simmons, Marisol A. Ramirez-Solano, Xiangzhu Zhu +48 more

Human colorectal pre-cancer atlas identifies distinct molecular programs underlying two major subclasses of pre-malignant tumors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.11.426044
Top 59%
0.262DataRank
Top 59%3 citations

Eliot T. McKinley, Alan J. Simmons, Marisol Ramirez‐Solano, Xiangzhu Zhu, Austin N. Southard-Smith +23 more

Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.08.010
N/A
0DataRank · unranked
1 citations

Chih–Yuan Hsu, Jeng-Fong Chiou, Lynne D. Berry, Leora Horn, Paul A. Bunn +5 more

Oncologist participation in pilot testing a crowdsourcing platform to build a survivorship care risk model.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e13568
N/A
0DataRank · unranked
0 citations

Li Ming Wen, Yanwei Li, Tatsuki Koyama, Lynne D. Berry, Tuya Pal +3 more

Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer

Journal of Clinical Investigation(2023)10.1172/jci160330
N/A
0DataRank · unranked
21 citations

Ruichen Rong, Donghan M. Yang, Junya Fujimoto, Justin A. Bishop, Shirley Yan +15 more